Quality of life in children requiring antithrombotic therapy: Development of a measure

Seminars in Thrombosis and Hemostasis

Volumn 37, Issue 7, 2011, Pages 834-839

  Bruce, Aisha A K ^a   Bauman, Mary E ^a   Massicotte, M Patricia ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

antithrombotic therapy; measurement; Pediatrics; quality of life

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; HEPARIN; REVIPARIN; WARFARIN;

ACCURACY; ANTICOAGULANT THERAPY; ARTICLE; CLINICAL RESEARCH; CONGENITAL HEART DISEASE; CONSTRUCT VALIDITY; HEALTH CARE; HEALTH CARE POLICY; HUMAN; LONG TERM CARE; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PRIORITY JOURNAL; PSYCHOMETRY; QUALITY OF LIFE; RELIABILITY; THROMBOEMBOLISM; THROMBOSIS; VALIDITY;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; CLINICAL TRIALS AS TOPIC; FIBRINOLYTIC AGENTS; HUMANS; OUTCOME ASSESSMENT (HEALTH CARE); PARENT-CHILD RELATIONS; PATIENT COMPLIANCE; QUALITY OF LIFE; QUESTIONNAIRES; THROMBOSIS;

EID: 84055222116     PISSN: 00946176     EISSN: 10989064     Source Type: Journal    
DOI: 10.1055/s-0031-1297175     Document Type: Article

References (35)

1. De Geest S, Sabaté E. Adherence to long-term therapies: evidence for action. Eur J Cardiovasc Nurs 2003 2 4 323 (Pubitemid 37518223)
2. Kuyken W. The World Health Organization Quality of Life assessment (WHOQOL): position paper from the World Health Organization. Soc Sci Med 1995 41 10 1403-1409
3. Marino B S., Shera D, Wernovsky G et al. The development of the pediatric cardiac quality of life inventory: a quality of life measure for children and adolescents with heart disease. Qual Life Res 2008 17 4 613-626
4. Colver A. Quality of life and participation. Dev Med Child Neurol 2009 51 8 656-659
5. Rosenbaum P. Children's quality of life: separating the person from the disorder. Arch Dis Child 2008 93 2 100-101 (Pubitemid 351204746)
6. Albrecht R. MCOs following innovative CMS remote monitoring initiative: self-testing service is designed to lower costs and improve outcomes for anticoagulation therapy. Manag Care Q 2006 14 1 13-16
7. Monagle P, Chalmers E, Chan A et al, American College of Chest Physicians. Antithrombotic therapy in neonates and children: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008 133 6, Suppl 887S-968S (Pubitemid 351892979)
8. Bruce A A., Bauman M E., Black K, Newton A, Legge L, Massicotte M P. Development and preliminary evaluation of the KIDCLOT PAC QL: a new health-related quality of life measure for pediatric long-term anticoagulation therapy. Thromb Res 2010 126 2 e116-e121
9. Samsa G, Matchar D B., Dolor R J. et al. A new instrument for measuring anticoagulation-related quality of life: development and preliminary validation. Health Qual Life Outcomes 2004 2 22
10. Samsa G P., Matchar D B. Relationship between test frequency and outcomes of anticoagulation: a literature review and commentary with implications for the design of randomized trials of patient self-management. J Thromb Thrombolysis 2000 9 3 283-292 (Pubitemid 30201262)
11. Jones S, Newall F, Manias E, Monagle P. Assessing outcome measures of oral anticoagulation management in children. Thromb Res 2011 127 2 75-80
12. Sabaté E. Adherence to Long-Term Therapies: Evidence for Action. World Health Organization. Geneva 2003
13. Chan VHT, Monagle P, Massicotte P, Chan A K. Novel paediatric anticoagulants: a review of the current literature. Blood Coagul Fibrinolysis 2010 21 2 144-151
14. Massicotte M P., Sofronas M, deVeber G. Difficulties in performing clinical trials of antithrombotic therapy in neonates and children. Thromb Res 2006 118 1 153-163
15. Sofronas M, Ichord R N., Fullerton H J. et al. Pediatric stroke initiatives and preliminary studies: What is known and what is needed? Pediatr Neurol 2006 34 6 439-445 (Pubitemid 43831575)
16. Streif W, Andrew M, Marzinotto V et al. Analysis of warfarin therapy in pediatric patients: A prospective cohort study of 319 patients. Blood 1999 94 9 3007-3014 (Pubitemid 29512704)
17. Massicotte P, Julian J A., Gent M et al, REVIVE Study Group. An open-label randomized controlled trial of low molecular weight heparin compared to heparin and coumadin for the treatment of venous thromboembolic events in children: the REVIVE trial. Thromb Res 2003 109 2-3 85-92 (Pubitemid 36428758)
18. Massicotte P, Julian J A., Gent M et al, PROTEKT Study Group. An open-label randomized controlled trial of low molecular weight heparin for the prevention of central venous line-related thrombotic complications in children: the PROTEKT trial. Thromb Res 2003 109 2-3 101-108 (Pubitemid 36428760)
19. McCrindle B W., Cochrane A, Roberts R et al. Factors associated with thrombotic complications in the first 2 years after the Fontan procedure: a multicentre prospective study. Circulation 2009 120 S591
20. Eiser C, Morse R. Can parents rate their child's health-related quality of life? Results of a systematic review. Qual Life Res 2001 10 4 347-357 (Pubitemid 33079013)
21. Guyatt G, Drummond M, Feeny D et al. Guidelines for the clinical and economic evaluation of health care technologies. Soc Sci Med 1986 22 4 393-408 (Pubitemid 16125470)
22. Guyatt G H., Bombardier C, Tugwell P X. Measuring disease-specific quality of life in clinical trials. CMAJ 1986 134 8 889-895 (Pubitemid 16013788)
23. Fanikos J, Stapinski C, Koo S, Kucher N, Tsilimingras K, Goldhaber S Z. Medication errors associated with anticoagulant therapy in the hospital. Am J Cardiol 2004 94 4 532-535 (Pubitemid 39120014)
24. Marks S D., Massicotte M P., Steele B T. et al. Neonatal renal venous thrombosis: clinical outcomes and prevalence of prothrombotic disorders. J Pediatr 2005 146 6 811-816 (Pubitemid 40840604)
25. Varni J W., Limbers C A. The pediatric quality of life inventory: measuring pediatric health-related quality of life from the perspective of children and their parents. Pediatr Clin North Am 2009 56 4 843-863
26. Burkhart P V., Sabaté E. Adherence to long-term therapies: evidence for action. J Nurs Scholarsh 2003 35 3 207 (Pubitemid 38591659)
27. Campbell J D. Illness is a point of view; the development of children's concept of illness. Child Dev 1975 46 1 92-100
28. Hart C, Chesson R. Children as consumers. BMJ 1998 316 7144 1600-1603 (Pubitemid 28234111)
29. Limbo R, Petersen W, Pridham K. Promoting safety of young children with guided participation processes. J Pediatr Health Care 2003 17 5 245-251 (Pubitemid 37324522)
30. Valderas J M., Kotzeva A, Espallargues M et al. The impact of measuring patient-reported outcomes in clinical practice: a systematic review of the literature. Qual Life Res 2008 17 2 179-193
31. Erikson E. Childhood and Society. New York, NY W.W. Norton 1985
32. Klaassen R J., Blanchette V S., Barnard D et al. Validity, reliability, and responsiveness of a new measure of health-related quality of life in children with immune thrombocytopenic purpura: the Kids' ITP Tools. J Pediatr 2007 150 5 510-515, 515, e1
33. Eiser C, Morse R. A review of measures of quality of life for children with chronic illness. Arch Dis Child 2001 84 3 205-211 (Pubitemid 32250825)
34. van Doorn C, Yates R, Tunstill A, Elliott M. Quality of life in children following mitral valve replacement. Heart 2000 84 6 643-647
35. Gonzalez B E., Teruya J, Mahoney D H. Jr et al. Venous thrombosis associated with staphylococcal osteomyelitis in children. Pediatrics 2006 117 5 1673-1679 (Pubitemid 46071396)